Showing results (41-50 of 205) with videos related to
Sort By:
Pageof 21
Oncology Research|October 20, 1999
In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenograftsK Song, K H Cowan, B K SinhaPhysical Review. E, Statistical, Nonlinear, and Soft Matter Physics|September 21, 2002
Reflectivity and energy balance in pulsed-laser deposition experiments from mono- and bi-atomic targetsT Müller, B K Sinha, K P RohrAnticancer Research|September 1, 1994
Potentiation of antitumor activities of carboplatin and camptothecin by interleukin-1 alpha against human ovarian carcinoma in vivoZ Wang, M N Benchekroun, B K SinhaChemico-Biological Interactions|January 1, 1987
Interactions of the antitumor drug, etoposide, with reduced thiols in vitro and in vivoA G Katki, B Kalyanaraman, B K SinhaPhysical Review. E, Statistical, Nonlinear, and Soft Matter Physics|March 15, 2003
Direction-selective free expansion of laser-produced plasmas from planar targetsTh Müller, B K Sinha, K P RohrBiochemical Pharmacology|May 25, 1993
Synergistic antiproliferative effects of interleukin-1 alpha and doxorubicin against the human ovarian carcinoma cell line (NIH:OVCAR-3)E Monti, E G Mimnaugh, B K SinhaBiochimica Et Biophysica Acta|January 22, 1993
Synergistic interactions of etoposide and interleukin-1 alpha are not due to DNA damage in human melanoma cellsE Monti, E G Mimnaugh, B K SinhaBiochimica Et Biophysica Acta|June 29, 1984
An electron spin resonance study of the reduction of peroxides by anthracycline semiquinonesB Kalyanaraman, R C Sealy, B K SinhaCancer Research|February 1, 1991
A role for the interleukin 1 receptor in the synergistic antitumor effects of human interleukin 1 alpha and etoposide against human melanoma cellsN Usui, E G Mimnaugh, B K SinhaIEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|January 1, 1989
Experimental verification of stress compensation in the SBTC-cutM Valdois, B K Sinha, J J BoyPageof 21